Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05730465 · ClinicalTrials.gov registry record · NA

Improving Blood Pressure Control in Stroke Patients by Increasing Access to a Home Blood Pressure Monitor

A NA study of Hypertension and Stroke, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05730465: Recruiting NA study of Hypertension and Stroke, sponsored by Stanford University.

NCT05730465 is a NA study of Hypertension and Stroke that is actively recruiting participants, run by Stanford University. The registered enrollment target is 50 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05730465, a NA study of Hypertension and Stroke, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn whether providing teaching with a low-cost device can help to improve blood pressure, health outcomes, patient self-efficacy without exacerbating inequity between advantaged and disadvantaged patients. The main question\[s\] it aims to answer are: 1. Does providing a free home blood pressure cuff improve control of hypertension? 2. Does providing a free home blood pressure cuff have a greater impact on control of hypertension in disadvantaged populations? 3. Does improved control of home blood pressure decrease adverse patient outcomes? Participants will be asked to * Take their blood pressure at home and records the results * Participate in follow-up phone calls from investigators at at 3 and 6 months Researchers will compare patients provided with home blood pressure monitors to those who are provided with routine education

Interventions

  • BEHAVIORAL Use of Omron Home Blood Pressure Cuff

Study Locations (1)

California

  • Stanford University Hospital - Palo Alto

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-05-01
Est. Completion 2025-04-30
Phase NA
Stanford University

1,744 total trials

What NCT05730465 shows while recruiting

NCT05730465 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower).

The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Use of Omron Home Blood Pressure Cuff is the first listed.

NCT05730465 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05730465 about?

NCT05730465 is a clinical study titled "Improving Blood Pressure Control in Stroke Patients by Increasing Access to a Home Blood Pressure Monitor". The goal of this clinical trial is to learn whether providing teaching with a low-cost device can help to improve blood pressure, health outcomes, patient self-efficacy without exacerbating inequity between advantaged and disadvantaged patients. The main question\[s\] it aims to answer are: 1. Doe...

What is the current status of trial NCT05730465?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-05-01. Estimated completion is 2025-04-30.

What conditions does trial NCT05730465 study?

This clinical trial studies the following conditions: Hypertension, Stroke, Vascular Diseases, TIA.

What interventions are being tested in trial NCT05730465?

The interventions under investigation include: Use of Omron Home Blood Pressure Cuff (BEHAVIORAL).

Who is sponsoring clinical trial NCT05730465?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05730465 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05730465's enrollment target sits among peer trials

50 367th of 470 higher than 96 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05730465, the US trial registry maintained by the National Library of Medicine. NCT05730465 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.